Researchers at the University of Waterloo have developed a new system that could significantly speed up the discovery of new drugs and reduce the need for costly and time-consuming laboratory tests.
The new technology called Pattern to Knowledge (P2K) can predict the binding of biosequences in seconds and potentially reduce bottlenecks in drug research.
P2K uses artificial intelligence (AI) to leverage deep knowledge from data instead of relying solely on classical machine learning.
“P2K is a game changer given its ability to reveal subtle protein associations entangled in complex physiochemical environments and powerfully predict interactions based only on sequence data,” said Andrew Wong, professor, Systems Design Engineering, and Founding Director, Centre for Pattern Analysis and Machine Intelligence (CPAMI). “The ability to access this deep knowledge from proven scientific results will shift biological research going forward. P2K has the power to transform how data could be used in the future.”
Although a large amount of biological sequence data has been collected, extracting meaningful and useful knowledge hasn’t been easy. P2K algorithms tackle this challenge by disentangling multiple associations to identify and predict amino acid bindings that govern protein interactions. Since P2K is much faster than existing biosequence analysis software with almost 30 per cent better prediction accuracy, it could significantly speed up the discovery of new drugs. By drawing information from databases in the Cloud, P2K could predict how tumour proteins and potential cancer treatments would interact.
Although still in the early prototype stage, Professor Wong and his team have made the online P2K system available publicly to researchers to start identifying new bio-sequence interactions.
“Putting this AI technology in the hands of biomedical researchers will generate immediate results, which could be used for future scientific discoveries,” said Antonio Sze-To, research associate, Systems Design Engineering, and co-inventor of P2K.
Since it analyzes sequential data, the applicability of P2K isn’t limited to biomedical research. P2K could benefit the financial industry by making useful associations and predictions for smart trading or the cybersecurity sector by predicting the likelihood of a potential cyber attack.
The Latest on: Drug discovery
via Google News
The Latest on: Drug discovery
- Use combined chemical probe resources to select best tools for biomedical research and drug discovery, scientists urgeon November 28, 2019 at 10:06 am
A major challenge is that the information about potential chemical probes is scattered across many different scientific publications and other sources, making it difficult for scientists to make a ...
- ‘Ilabas mo’: Duterte dares Robredo to release drug war discoveryon November 28, 2019 at 4:29 am
MANILA, Philippines—President Rodrigo Duterte on Thursday dared Vice President Leni Robredo to release her supposed discovery in the administration’s drug war. “You seem to be threatening na may ...
- Drug Discovery Informatics Market Competitive Analysis and Forecasts till 2024on November 27, 2019 at 12:18 am
Drug Discovery Informatics Market – Growth, Trends, And Forecast (2019 – 2024) this market research provides an analysis of the most important trends expected to impact the market outlook during the ...
- AI for Drug Discovery Market 2019-2027 / Trends, Development, Revenue, Demand And Forecaston November 26, 2019 at 10:33 pm
Nov 27, 2019 (AmericaNewsHour) -- The report covers the forecast and analysis of the AI for drug discovery market on a global and regional level. The study provides historical data from 2015 to 2018 ...
- Artificial Intelligence for Drug Discovery Market Size Worth US$ 8,419 Mn by 2026on November 26, 2019 at 2:40 pm
LOS ANGELES, Nov. 26, 2019 (GLOBE NEWSWIRE) -- The global artificial intelligence for drug discovery market is expected to reach around US$ 8,149 Million by 2026 with a CAGR of above 42% during the ...
- The global AI in the drug discovery market is projected to reach USD 1,434 million by 2024 from USD 259 million in 2019, at a CAGR of 40.8%on November 25, 2019 at 4:12 pm
Growing number of cross-industry collaborations and partnerships and the need to control drug discovery & development costs and reduce the overall time taken in this process are the key factors ...
- Immunitas Therapeutics Gets $39 Million for Cancer Drug Discoveryon November 21, 2019 at 6:50 pm
Venture firm Longwood Fund has founded and raised $39 million in venture funding for Immunitas Therapeutics Inc., a startup harnessing an emerging technology known as single-cell sequencing to develop ...
- With Cell-By-Cell Take on Drug Discovery, Immunitas Debuts With $39Mon November 21, 2019 at 4:37 pm
The idea is that a drug developed from those samples would be targeted at that group. It is also looking to set itself apart from other drug discovery efforts by analyzing human samples, avoiding the ...
- AI in drug discovery market to increase at CAGR of 40.8 percenton November 20, 2019 at 7:03 am
Research has found that artificial intelligence in drug discovery will be worth $1,434 million by the end of 2024. New research has found that artificial intelligence (AI) in the drug discovery market ...
via Bing News